South African Health Products Regulatory Authority
AgencySAHPRA
Mandate
Regulates health products, medicines and medical devices.
What Govermate has read
Updated 10 Nov 2026Built from the documents Govermate has read from SAHPRA. Every line below comes from a source document, not from an editorial description.
What this body does
- Publishes statements381 documentsfrom what documents state
- Offers opportunities or services200 documentsfrom links between records
- Offers opportunities or services119 documentsfrom what documents state
- medicine safety alert5 documentsdescribed in documents
- a product recall notice from a regulatory authority2 documentsdescribed in documents
- a product registration notice from a health regulatory authority2 documentsdescribed in documents
- a regulatory guideline document2 documentsdescribed in documents
- A SAHPRA News & Updates entry announcing regulatory guidance for COVID-19…1 documentdescribed in documents
- A SAHPRA communication about implementing the SASQART radiotherapy…1 documentdescribed in documents
- A SAHPRA communication to medical radionuclide authority holders about delayed…1 documentdescribed in documents
- A SAHPRA document page titled “Riqviva 100 and 400 (Bevacizumab)”; the supplied1 documentdescribed in documents
- A SAHPRA media release explaining the regulatory approval process and status of1 documentdescribed in documents
209 further descriptions not shown.
Recent activity
- Requirements For Obtaining A Pharmacy Licence And Complying With The Pharmacy Act 53 Of 1974 And The Medicines And Related Substances Act 101 Of 1965
This SAHPRA web page is titled as a document setting out requirements for obtaining a pharmacy licence and complying with the Pharmacy Act 53 of 1974 and the Medicines and Related Substances Act 101 of 1965. The supplied text is almost entirely site navigation, so the actual requirements are not visible in the excerpt.
- Mycophenolate Mofetil Mmf Containing Products Risk Of Pregnancy Loss And Congenital Malformations Extension Of The Post Treatment Contraception Period From 6…
SAHPRA's safety communication reports that the post-treatment contraception period for women of childbearing potential taking mycophenolate mofetil (MMF)-containing products is extended from 6 weeks to 6 months, because of the risk of pregnancy loss and congenital malformations. It is directed at prescribers and patients as a labelling and safety update.
- SAHPRA/2026/RENEWAL OF VEEAM DATA CLOUD FOR MICROS
SAHPRA has published an open Request for Bid to renew its Veeam Data Cloud subscription for Microsoft 365. The contract covers 36 months with an option to renew for a further 24 months. Bids close on 24 November 2026 at 11:00.
- Esenta Stomahesive Paste
- Sahpra Inspires Rhodes Science Students To Shape The Future Of Health Regulation
This document is a SAHPRA (South African Health Products Regulatory Authority) news item posted on 20 July 2026. It reports that SAHPRA participated in Rhodes University’s Career Day on 9 July 2026 at the Makhanda campus to inspire approximately 200 pharmacy and science students to pursue careers in health product regulation. Students interacted with SAHPRA experts across Pharmacovigilance, Inspectorate, Performance Evaluation and Monitoring, HR, Finance and Communications, and learned about SAHPRA’s role in ensuring quality, safety and efficacy of health products and about graduate opportunities such as internships and learnerships.
- Updates On The Regulation Of Advertising Of Health Products Webinar
This document is a SAHPRA (South African Health Products Regulatory Authority) event listing for a webinar titled “Updates on the Regulation of Advertising of Health Products.” SAHPRA invites industry stakeholders to attend and explains that the webinar will cover current and planned initiatives to strengthen regulation of advertising and promotion of medicines and medical devices, including increased post-marketing surveillance and possible introduction of a pre-approval process. It also announces an upcoming industry survey and a pilot study on active monitoring of advertising planned to commence on 1 September 2026. The webinar took place on 28 July from 3:00 pm to 4:00 pm and was held virtually.
Upgrade your account to take action
See plansOpportunity signal
54 classified as something a person can apply for, 260 identified by reading.
Recent Opportunities
View allSAHPRA has published an open Request for Bid to renew its Veeam Data Cloud subscription for Microsoft 365. The contract covers 36 months with an option to renew for a further 24 months. Bids close on 24 November 2026 at 11:00.
This is an active open Request for Quotation issued by the South African Health Products Regulatory Authority for catering for a Wellness Day at its Cape Town office. The quotation period opens on 29 September 2026 and closes on 6 October 2026 at 11:00, with delivery listed for 35 Carl Cronje Drive, Tyger Valley, Bellville.
This is an open tender notice issued by the South African Health Products Regulatory Authority. It seeks bids for printing corporate material and for design, layout, editing and proofreading services over 36 months, with bids due by 6 October 2026 at 11:00. A non-compulsory briefing session will be held online on 17 September 2026.
This is a tender published by South African Health Products Regulatory Authority. It is not currently shown as open for applications. Review the source evidence for the official status and details.
This document is a media statement from SAHPRA announcing that it inspired TUT students to consider careers in health regulation. The visit was aimed at promoting interest in regulatory roles within the health products sector. No formal application or registration process is described.
This document is an open-tender (Request for Bid) record for “RFB001” titled an integrated communication and public awareness campaign for the South African Health Products Regulatory Authority (SAHPRA). The tender is for programming and broadcasting services, with delivery at 402 Kirkness Street, Arcadia, Pretoria (0083). The tender period runs from 13 July 2026 to 6 August 2026 at 11:00, and the contact person is Malose Teffo (malose.teffo@sahpra.org.za, 012-501-0327).
Recent documents
Published by SAHPRA. These are records Govermate has read from this institution, not opportunities to apply for.
- Requirements For Obtaining A Pharmacy Licence And Complying With The Pharmacy Act 53 Of 1974 And The Medicines And Related Substances Act 101 Of 1965Year: 1974
- Esenta Stomahesive Paste
- Mycophenolate Mofetil Mmf Containing Products Risk Of Pregnancy Loss And Congenital Malformations Extension Of The Post Treatment Contraception Period From 6 Weeks To 6 Months ForNotices & forms
- Field Safety Corrective Actions
- Riqviva 100 And 400 Bevacizumab
- Guideline On The Quality And Clinical Aspects Of Synthetic PeptidesNotices & forms